化工社
首页MCP工作台Skills
首页工作台通知我的
llms.txt · MCP 指南隐私政策 · 服务条款 · 支持v1.8.3
  1. 首页
  2. /化合物

alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/24:0)

HCID 178940722
新建反应
打印

正在补全数据,稍后刷新页面可查看最新内容

基本信息概述名称与标识性质相关反应化合物笔记
子结构检索查找相似结构

基本信息

CAS
82005-99-0
标准SMILES
CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCCCCCCCC
InChIKey
MRVRZXMLIKCXOT-SHLWWNIASA-N
分子式
C60H113NO18
平均分子量
1,136.5 g/mol

概述

Alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/24:0) is a glycotriaosylceramide having alpha-D-galactosyl-(14)-beta-D-galactosyl-(14)-beta-D-glucosyl as the glycotriaosyl component attached to the Cer(d18:1/24:0). It has a role as a mouse metabolite. It is functionally related to a tetracosanoic acid.

名称与标识

首选名称
alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/24:0)
IUPAC
N-[(E,2S,3R)-1-[(2R,3R,4R,5S,6R)-5-[(2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]tetracosanamide
英文名
(2S,3R,4E)-2-(Tetracosanoylamino)-1-[4-O-(4-O-α-D-galactopyranosyl-β-D-galactopyranosyl)-β-D-glucopyranosyloxy]-4-octadecen-3-ol
分子式
C60H113NO18
分子量
1136.54

名称与别名

GLOBOTRIAOSYLCERAMIDE PORCINEGb3(d18:1/24:0)alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/24:0)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)Hex3Cer 42:1;O2LMSP0502AA05orb1693962Globotriaosylceramides (porcine)CHEBI:84695C60H113NO18AKOS040755104T36186
展开更多名称
(2S,3R,4E)-2-(Tetracosanoylamino)-1-[4-O-(4-O-α-D-galactopyranosyl-β-D-galactopyranosyl)-β-D-glucopyranosyloxy]-4-octadecen-3-ol
Q27157995N-[(2S,3R,4E)-1-{[alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]tetracosanamideN-[(E,1S,2R)-1-[[(2R,3R,4R,5S,6R)-5-[(2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]-2-hydroxy-heptadec-3-enyl]tetracosanamideN-[(E,2S,3R)-1-[(2R,3R,4R,5S,6R)-5-[(2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]tetracosanamide

数据库标识

CAS
82005-99-0
ChEBI
CHEBI:84695
Nikkaji
J187.535C

性质

结构计算性质补全中

XLogP
11.3
极性表面积
307 Ų
氢键供体
12
氢键受体
18
可旋转键
47
重原子
79
形式电荷
0
复杂度
1,500

实验与物化性质

LipidsLipids -> Sphingolipids [SP] -> Neutral glycosphingolipids [SP05] -> Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]

物理化学性质

沸点
1162.457 · 1162.457±65.00 °C(Press: 760.00 Torr)(predicted)
密度
1.191 · 1.191±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
酸度系数(pKa)
12.76 · 12.760±0.70(predicted)

相关反应

0 条
新建反应记录
还没有相关反应

化合物笔记

本页导航基本信息概述名称与标识性质相关反应化合物笔记